AECOM Share Price Target ‘$108.56’, now 21.2% Upside Potential

DirectorsTalk Interviews

AECOM with ticker code (ACM) have now 9 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $116.00 and $100.00 calculating the mean target share price we have $108.56. (at the time of writing). Given that the stocks previous close was at $89.57 and the analysts are correct then we can expect a percentage increase in value of 21.2%. Also worth taking note is the 50 day moving average now sits at $93.99 and the 200 day MA is $88.35. The total market capitalization for the company now stands at 12.27B. The stock price is currently at: $90.14 USD

The potential market cap would be $14,871,991,066 based on the market consensus.

The company has a dividend yield of 0.03%. Other points of data to note are a P/E ratio of 103.61, revenue per share of $111.89 and a 4.65% return on assets.

AECOM is a global provider of professional infrastructure consulting services for governments, businesses, and organizations across the world. The Company operates through three segments: Americas, International, and AECOM Capital (ACAP). The Americas segment provides planning, consulting, architectural and engineering design, and construction and program management services to commercial and government clients in the United States, Canada, and Latin America in end markets, such as transportation, water, government, facilities, environmental, and energy. The International segment offers planning, consulting, architectural and engineering design services and program management to commercial and government clients in Europe, the Middle East, Africa and the Asia-Pacific regions in end markets, such as transportation, water, government, facilities, environmental, and energy. The ACAP segment invests primarily in and develops real estate projects.

Share on:

Latest Company News

Dunelm reports solid H1 FY26 sales growth amid challenging market conditions

Dunelm Group plc announced Interim Results for the 26 weeks to 27 December 2025, reporting total sales growth of 3.6% to £926.3m and increased market share despite a softer second quarter.

Bellway reports higher completions and maintains FY26 guidance

Bellway said first-half housing completions rose to 4,702 homes, with revenue up over 6% to £1.51bn, despite softer reservation rates through the autumn.

Verici Dx: Tutivia Set to Disrupt Transplant Monitoring with Real-Time RNA Insights (Video)

Tutivia is turning heads in transplant care. Verici Dx CEO Sara Barrington explains how their RNA-based rejection test is setting new standards in real-world use—and why clinicians and payers are getting on board.

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International.

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress.

Ethtry: Ethereum Treasuries, Nation-State Partnerships and the Web3 Bet You’re Not Watching (Video)

Ethtry’s CEO Patrick Chopard reveals how the company is building a next-gen operating model by combining Ethereum-based treasuries with traditional business infrastructure—anchored by partnerships with LTIM and AMINA Bank.

    Search

    Search